ALGS
NASDAQ
US
Aligos Therapeutics, Inc. - Common stock
$7.97
▲ +$0.23
(+2.97%)
Vol 40K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$57.4M
ROE
-4.5%
Margin
-3267.7%
D/E
0.20
Beta
2.75
52W
$4–$47
Wall Street Consensus
11 analysts · Apr 20263
Strong Buy
7
Buy
1
Hold
0
Sell
0
Strong Sell
90.9%
Buy Rating
Price Chart
Similar Stocks
ATOS
Atossa Therapeutics Inc
$76.2M
LSTA
Lisata Therapeutics Inc
$16.4M
ESLA
Estrella Immunopharma Inc
$58.9M
RLYB
Rallybio Corp
$29.0M
ATRA
Atara Biotherapeutics Inc
P/E 5.6
$130.4M
LITS
Lite Strategy Inc
$48.6M
SNSE
Sensei Biotherapeutics Inc
$13.5M
CELU
Celularity Inc
$31.6M
CRVO
CervoMed Inc
$73.1M
NXTC
NextCure Inc
$49.7M
Earnings
Beat rate: 50.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-1.89 | $-1.91 | $-0.02 |
| Sep 2025 | $-1.94 | $-3.04 | $-1.10 |
| Jun 2025 | $-2.41 | $-1.53 | +$0.88 |
| Mar 2025 | $-2.85 | $-2.11 | +$0.74 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 8.9% | 37.1% | 8.9% | 8.9% | -4.5% | -4.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -1643.8% | -1628.8% | -2337.2% | -2337.2% | -3267.7% | -3267.7% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.16 | 0.14 | 0.16 | 0.16 | 0.20 | 0.20 |
| Current Ratio | 6.31 | 7.56 | 6.31 | 6.31 | 4.70 | 4.70 |
Key Ratios
ROA (TTM)
-74.3%
P/S (TTM)
21.67
P/B
0.5
EPS (TTM)
$-12.70
CF/Share
$-1.86
Rev Growth 3Y
-3.3%
52W High
$46.80
52W Low
$3.76
$3.76
52-Week Range
$46.80
How does ALGS compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ALGS valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
21.7
▲
69%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
0.5
▼
78%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ALGS profitability vs Biotechnology peers
ROE
-4.5%
▲
93%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-3267.7%
▼
1040%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-74.3%
▼
59%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
ALGS financial health vs Biotechnology peers
D/E ratio
0.2
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
In line
Current ratio
4.7
▲
6%
above
peers
(4.4)
vs Peers
vs Industry
In line
Beta
2.8
▲
183%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
ALGS fundamentals radar
ALGS
Peer median
Industry
ALGS profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ALGS vs peers: key metrics
Latest News
No related news yet